Eli Lilly and Company

Cathleen Alice Cantwell

Stephen W Queener

Matthew Dale Hilton

Dennis Nelson Thomas

Andrew Richard Cockshott

Roland L Hodges

Robert Joseph Strobel, Jr

Brian Gerald Getman

Penelope Jane Beverly Millar

Jack Richard Eastridge

Paul Luther Skatrud

JoAnn Hoskins

Joseph M Zock

Derek McGilvray

James R Swartling

A method for producing one or more pseudomycins is described including cultures ofthat produce one or more pseudomycins having general formula (I) where R is a lipophilic moiety. 

Pseudomycin production by pseudomonas syringae

The present invention is directed to a family of unique antimycotic lipopeptide compounds produced by. The lipopeptides are effective against both human and plant fungal pathogens, and are typically characterized by their ability to inhibit growth of. Representative lipopeptides of the invention have molecular weights of 1137, 1153, 1164 and 1181 daltons.

Pseudomycin production by Pseudomonas syringae

The present invention provides DNA compounds that encode ACV synthetase activity of,. The compounds can be used to construct recombinant DNA expression vectors for a wide variety of host cells, including,, Penicillium, Cephalosporium, and Aspergillus.

Recombinant DNA compounds that encode ACV synthetase activity of Cephalosporium acremonium

The present invention provides isolated DNA compounds and recombinant DNA cloning and expression vectors that encode PNB esterase from Bacillus subtilis. The invention also provides host cells transformed with these vectors and a method for production of the PNB esterase by recombinant DNA techniques.

Recombinant DNA compounds and expression vectors encoding

Growing community of inventors

Indianapolis, IN, United States of America

Cathleen Alice Cantwell